<p>, /PRNewswire/ -- Biocoat 今天宣佈成立 Surmodics Services &amp; Technologies，這是一個新命名的部門，將繼續推進 Biocoat 在與 Surmodics 合併後剩餘的業務部分，並在交易中剝離某些 Biocoat 資產。</p>
<p>Surmodics Services &amp; Technologies 代表了未被剝離的 Biocoat 傳統業務運營。該部門現在將作為 Surmodics 組織的一部分以新名稱運營。Surmodics Services &amp; Technologies 總部位於賓夕法尼亞州霍舍姆，將繼續為全球醫療器械製造商提供一系列先進的親水性和其他塗層技術以及專業服務。www.SurmodicsST.com</p>
<p>Surmodics Services &amp; Technologies 作為一個靈活且高度以客户為中心的組織，旨在與醫療器械製造商在開發過程的每個階段緊密合作。該部門的項目開發和工程團隊擁有數十年的專業知識，能夠快速可靠地從早期概念推進到商業化。</p>
<p>霍舍姆設施為初創企業、合同製造商和主要原始設備製造商提供完全可擴展的解決方案。該部門具備從早期配方、可行性測試、優化到全塗層生產的端到端能力，旨在加速創新並支持設備的整個生命週期。</p>
<p>&#34;今天標誌着我們組織和我們服務的客户的重要里程碑，&#34; Surmodics 首席執行官 Chip Hance 説。&#34;通過 Surmodics Services &amp; Technologies，我們繼續建立一個專注、靈活且以創新為驅動的部門，基於數十年的科學卓越。在這個新身份下，我們將繼續與設備製造商緊密合作，將下一代醫療技術帶給全球患者。&#34;</p>
<p><strong>關於 Surmodics Services &amp; Technologies</strong></p>
<p>Surmodics Services &amp; Technologies 是 Surmodics 的一個部門，提供先進的親水塗層解決方案、自定義聚合物配方和醫療器械行業的全方位塗層服務。總部位於賓夕法尼亞州霍舍姆，SST 支持客户從早期開發到全面生產，並與初創企業、合同開發製造組織（CDMO）和原始設備製造商（OEM）合作，加速創新並提升設備性能。</p>
<p><strong>關於 Surmodics, Inc.</strong></p>
<p>Surmodics 是為血管內醫療設備提供性能塗層技術以及為體外診斷免疫測定測試和微陣列提供化學和生物組件的領先供應商。Surmodics 還開發和商業化高度差異化的血管介入醫療設備，旨在滿足未滿足的臨牀需求，並按照最嚴格的要求進行工程設計。該關鍵增長戰略利用了公司在專有表面改性和藥物輸送塗層技術方面的專業知識，以及其設備設計、開發和製造能力。公司的使命是改善疾病的檢測和治療。Surmodics 總部位於明尼蘇達州伊登草原。有關更多信息，請訪問 www.surmodics.com。</p>
<p>來源：Biocoat, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz"/></p>

SRDX

<p>Biocoat 宣佈成立 Surmodics Services & Technologies，這是在與 Surmodics 合併並剝離某些資產後成立的新部門。該部門將在 Surmodics 旗下運營，專注於為醫療設備製造商提供親水塗層技術和服務。其目標是加速創新，並在設備的整個生命週期內提供支持，採用以客户為中心的方法，並具備開發和工程方面的專業知識</p>

<p>, /PRNewswire/ -- Biocoat today announced the formation of Surmodics Services &amp; Technologies, a newly named division that will carry forward the portion of Biocoat's business remaining after merging with Surmodics and divesting certain Biocoat assets in connection with the transaction.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Biocoat 今天宣佈成立 Surmodics Services &amp; Technologies，這是一個新命名的部門，將繼續推進 Biocoat 在與 Surmodics 合併後剩餘的業務部分，並在交易中剝離某些 Biocoat 資產。</p>
</div><p>Surmodics Services &amp; Technologies represents the legacy Biocoat business operations that were not divested. This division will now operate as part of the Surmodics organization under its new name. Based in Horsham, Pennsylvania, Surmodics Services &amp; Technologies will continue delivering an array of advanced hydrophilic and other coating technologies as well as specialized services to medical device manufacturers worldwide. www.SurmodicsST.com</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 代表了未被剝離的 Biocoat 傳統業務運營。該部門現在將作為 Surmodics 組織的一部分以新名稱運營。Surmodics Services &amp; Technologies 總部位於賓夕法尼亞州霍舍姆，將繼續為全球醫療器械製造商提供一系列先進的親水性和其他塗層技術以及專業服務。www.SurmodicsST.com</p>
</div><p>Structured as a nimble and highly customer-centric organization, Surmodics Services &amp; Technologies is designed to work closely with medical device manufacturers at every stage of the development process. The division's Project Development and Engineering team brings decades of expertise, enabling fast and reliable progression from early concept through commercialization.</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 作為一個靈活且高度以客户為中心的組織，旨在與醫療器械製造商在開發過程的每個階段緊密合作。該部門的項目開發和工程團隊擁有數十年的專業知識，能夠快速可靠地從早期概念推進到商業化。</p>
</div><p>The Horsham facility provides fully scalable solutions for start-ups, contract manufacturers, and major original equipment manufacturers. With end-to-end capabilities that include early-stage formulation, feasibility testing, optimization, and full coating production, the division is positioned to accelerate innovation and support devices across their full lifecycle.</p>
<div class="lb-trans"><p>霍舍姆設施為初創企業、合同製造商和主要原始設備製造商提供完全可擴展的解決方案。該部門具備從早期配方、可行性測試、優化到全塗層生產的端到端能力，旨在加速創新並支持設備的整個生命週期。</p>
</div><p>&#34;Today marks a significant milestone for our organization and for the customers we serve,&#34; said Chip Hance, CEO of Surmodics. &#34;With Surmodics Services &amp; Technologies, we continue with a focused, agile, and innovation-driven division built on decades of scientific excellence. Under this new identity, we will continue to partner closely with device manufacturers to bring next-generation medical technologies to patients around the world.&#34;</p>
<div class="lb-trans"><p>&#34;今天標誌着我們組織和我們服務的客户的重要里程碑，&#34; Surmodics 首席執行官 Chip Hance 説。&#34;通過 Surmodics Services &amp; Technologies，我們繼續建立一個專注、靈活且以創新為驅動的部門，基於數十年的科學卓越。在這個新身份下，我們將繼續與設備製造商緊密合作，將下一代醫療技術帶給全球患者。&#34;</p>
</div><p><strong>About Surmodics Services &amp; Technologies</strong></p>
<div class="lb-trans"><p><strong>關於 Surmodics Services &amp; Technologies</strong></p>
</div><p>Surmodics Services &amp; Technologies is a division of Surmodics that provides advanced hydrophilic coating solutions, custom polymer formulations, and full-service coating operations for the medical device industry. Headquartered in Horsham, Pennsylvania, SST supports customers from early-stage development through full production and partners with start-ups, CDMOs, and OEMs to accelerate innovation and enhance device performance.</p>
<div class="lb-trans"><p>Surmodics Services &amp; Technologies 是 Surmodics 的一個部門，提供先進的親水塗層解決方案、自定義聚合物配方和醫療器械行業的全方位塗層服務。總部位於賓夕法尼亞州霍舍姆，SST 支持客户從早期開發到全面生產，並與初創企業、合同開發製造組織（CDMO）和原始設備製造商（OEM）合作，加速創新並提升設備性能。</p>
</div><p><strong>About Surmodics, Inc.</strong></p>
<div class="lb-trans"><p><strong>關於 Surmodics, Inc.</strong></p>
</div><p>Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company's expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company's mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com.</p>
<div class="lb-trans"><p>Surmodics 是為血管內醫療設備提供性能塗層技術以及為體外診斷免疫測定測試和微陣列提供化學和生物組件的領先供應商。Surmodics 還開發和商業化高度差異化的血管介入醫療設備，旨在滿足未滿足的臨牀需求，並按照最嚴格的要求進行工程設計。該關鍵增長戰略利用了公司在專有表面改性和藥物輸送塗層技術方面的專業知識，以及其設備設計、開發和製造能力。公司的使命是改善疾病的檢測和治療。Surmodics 總部位於明尼蘇達州伊登草原。有關更多信息，請訪問 www.surmodics.com。</p>
</div><p>SOURCE Biocoat, Inc.</p>
<div class="lb-trans"><p>來源：Biocoat, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjEwJk5ld3NJdGVtSWQ9UEg0MzcwMyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTAxMjA3UFJfTkVXU19VU1BSX19fX19QSDQzNzAz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH43703&amp;Transmission_Id=202512101207PR_NEWS_USPR_____PH43703&amp;DateId=20251210"/></p>

Biocoat 宣佈在合併和剝離交易後成立 Surmodics 服務與技術部門